References
- Donegan CC Jr, MacIlwaine WA, Leavell BS. Hematologic studies on patients with sickle cell anemia following multiple transfusions. Am J Med 1954;17:29-35.
- Chaplin H Jr, Keitel HG, Peterson RE. Hematologic observations on patients with sickle cell anemia sustained at normal hemoglobin levels by multiple transfusions. Blood 1956;11:834-45.
- Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81: 1109-23.
- Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group [published erratum appears in N Engl J Med 2000;824:343]. N Engl J Med 2000;342: 1855-65.
- Green M, Hall RJ, Huntsman RG, Lawson A, Pearson TC, Wheeler, PC. Sickle cell crisis treated by exchange transfusion. Treatment of two patients with heterozygous sickle cell syndrome. JAMA 1975;231:948-50.
- Russell MO, Goldberg HI, Reis L, et al. Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. J Pediatr 1976;88:382-7.
- Lanzkowsky P, Shende A, Karayalcin G, Kim YJ, Aballi AJ. Partial exchange transfusion in sickle cell anemia. Use in children with serious complications Am J Dis Child 1978 Dec;132(12): 1206-8.
- Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990;76:1431-7.
- Blumberg N. Ross K, Avila E, Peck K. Should chronic transfusion be matched for antigens other than ABO and Rho(D)? Vox Sang 1984;47:205-8.
- Orlina AR, Unger PJ, Koshy M. Post-transfusion alloimmunization in patients with sickle cell disease. Am J Hematol 1978;5:101-6.
- Sarnaik S, Schornack J, Lusher JM. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986;26:249-52.
- Davies SC, McWilliam AC, Hewitt PE, et al. Red cell alloimmunization in sickle cell disease. Br J Haemotol 1986;63:241-5.
- Ambruso DR, Githens JH, Alcorn R, et al. Experience with donors matched for minor blood group antigens in patients with sickle cell anemia who are receiving chronic transfusion therapy. Transfusion 1987; 27:94-8.
- Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994;34:562-9.
- Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patents with sickle cell disease: theoretical and practical implications. Transfusion 2002;42:684-90.
- Sosler SD, Jilly BJ, Saporito C, Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 1993;43:103-6.
- Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002;42:37-43.
- Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-52.
- Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego: American Press, 2003.